Trends in ocular therapy.
D002800:Cholinesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D004336:Drug Antagonism; D004357:Drug Synergism; D005128:Eye Diseases / Q000188:drug therapy*; D006801:Humans; D008916:Miotics / Q000627:therapeutic use; D009411:Nerve Endings / Q000187:drug effects; D010277:Parasympathomimetics / Q000627:therapeutic use; D011955:Receptors, Drug; D013565:Sympatholytics / Q000627:therapeutic use; D013566:Sympathomimetics / Q000627:therapeutic use
D002800:Cholinesterase Inhibitors; D008916:Miotics; D010277:Parasympathomimetics; D011955:Receptors, Drug; D013565:Sympatholytics; D013566:Sympathomimetics